Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Foght Enterprises was a specialized business advisory firm focused on the international healthcare and life sciences sectors. Founded by Dr. James L. Foght, the firm leveraged his extensive experience in pharmaceutical management and investment banking to provide strategic consulting services. Dr. Foght was a co-founder of Vector Securities International and previously held senior roles at DuPont Pharmaceuticals, where he led European operations. The company primarily served as a vehicle for Dr. Foght's advisory work, including technology evaluation and investment strategy for life science funds. Following Dr. Foght's passing in 2023, the firm is no longer active in its primary capacity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Foght Enterprises.